| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rose Chesworth, Leonora E Long, Cynthia Shannon Weickert, Tim Kar. The Endocannabinoid System across Postnatal Development in Transmembrane Domain Frontiers in psychiatry. vol 9. 2020-09-30. PMID:29467679. |
the endocannabinoid system across postnatal development in transmembrane domain the use of cannabis is a well-established component risk factor for schizophrenia, particularly in adolescent individuals with genetic predisposition for the disorder. |
2020-09-30 |
2023-08-13 |
mouse |
| Koby Cohen, Aviv Weinstei. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review. Brain sciences. vol 8. issue 3. 2020-09-30. PMID:29495540. |
the effects of cannabinoids on executive functions: evidence from cannabis and synthetic cannabinoids-a systematic review. |
2020-09-30 |
2023-08-13 |
human |
| Koby Cohen, Aviv Weinstei. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review. Brain sciences. vol 8. issue 3. 2020-09-30. PMID:29495540. |
these synthetic cannabinoid drugs are associated with undesired adverse effects similar to those seen with cannabis use, yet, in more severe and long-lasting forms. |
2020-09-30 |
2023-08-13 |
human |
| Koby Cohen, Aviv Weinstei. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review. Brain sciences. vol 8. issue 3. 2020-09-30. PMID:29495540. |
specific search strategies were employed using multiple keywords (e.g., "synthetic cannabinoids and cognition," "cannabis and cognition" and "cannabinoids and cognition"). |
2020-09-30 |
2023-08-13 |
human |
| Alessandra Morano, Pierangelo Cifelli, Paolo Nencini, Letizia Antonilli, Jinane Fattouch, Gabriele Ruffolo, Cristina Roseti, Eleonora Aronica, Cristina Limatola, Carlo Di Bonaventura, Eleonora Palma, Anna Teresa Giallonard. Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin. Epilepsia open. vol 1. issue 3-4. 2020-09-30. PMID:29588939. |
cannabidivarin (cbdv) and cannabidiol (cbd) have recently emerged among cannabinoids for their potential antiepileptic properties, as shown in several animal models. |
2020-09-30 |
2023-08-13 |
Not clear |
| Vadim Yuferov, Eduardo R Butelman, Mary Jeanne Kree. Gender-specific association of functional Neuropsychiatric disease and treatment. vol 14. 2020-09-30. PMID:29713172. |
the main active component of cannabis is delta 9-tetrahydrocannabinol (delta 9-thc), a partial agonist of the cannabinoid type 1 receptor. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pinja Leimuranta, Leonard Khiroug, Rashid Giniatulli. Emerging Role of (Endo)Cannabinoids in Migraine. Frontiers in pharmacology. vol 9. 2020-09-30. PMID:29740328. |
finally, we present our view on perspectives of cannabis-derived (extracted or synthetized marijuana components) or novel endocannabinoid therapeutics in migraine treatment. |
2020-09-30 |
2023-08-13 |
Not clear |
| J Sebastian Richter, Véronique Quenardelle, Olivier Rouyer, Jean Sébastien Raul, Rémy Beaujeux, Bernard Gény, Valérie Wolf. A Systematic Review of the Complex Effects of Cannabinoids on Cerebral and Peripheral Circulation in Animal Models. Frontiers in physiology. vol 9. 2020-09-30. PMID:29896112. |
while cannabis is perceived as a relatively safe drug by the public, accumulating clinical data suggest detrimental cardiovascular effects of cannabinoids. |
2020-09-30 |
2023-08-13 |
Not clear |
| Rachel D Hutchison, Benjamin M Ford, Lirit N Franks, Catheryn D Wilson, Azure L Yarbrough, Ryoichi Fujiwara, Mark K Su, Denise Fernandez, Laura P James, Jeffery H Moran, Amy L Patton, William E Fantegrossi, Anna Radominska-Pandya, Paul L Prathe. Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ Frontiers in pharmacology. vol 9. 2020-09-30. PMID:30319418. |
atypical pharmacodynamic properties and metabolic profile of the abused synthetic cannabinoid ab-pinaca: potential contribution to pronounced adverse effects relative to Δ recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (scbs) can result in anxiety, psychosis, chest pain, seizures and death. |
2020-09-30 |
2023-08-13 |
Not clear |
| Anita Cservenka, Sarah Lahanas, Julieanne Dotson-Bosser. Marijuana Use and Hypothalamic-Pituitary-Adrenal Axis Functioning in Humans. Frontiers in psychiatry. vol 9. 2020-09-30. PMID:30327619. |
preclinical studies suggest cannabinoids affect functioning of the hypothalamic-pituitary-adrenal (hpa) axis, but little is known about the effects of marijuana (mj) use on hpa axis functioning in humans. |
2020-09-30 |
2023-08-13 |
Not clear |
| Dicky Struik, Fabrizio Sanna, Liana Fattor. The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity. Frontiers in behavioral neuroscience. vol 12. 2020-09-30. PMID:30416437. |
similarly to other drugs of abuse, the prevalence of cannabis use and addiction differs remarkably between males and females, suggesting that sex plays a role in regulating cannabinoid sensitivity. |
2020-09-30 |
2023-08-13 |
Not clear |
| Dicky Struik, Fabrizio Sanna, Liana Fattor. The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity. Frontiers in behavioral neuroscience. vol 12. 2020-09-30. PMID:30416437. |
although it remains unclear how sex may affect the initiation and maintenance of cannabis use in humans, animal studies strongly suggest that endogenous sex hormones modulate cannabinoid sensitivity. |
2020-09-30 |
2023-08-13 |
Not clear |
| Nirit Bernstein, Jonathan Gorelick, Roei Zerahia, Sraya Koc. Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis ( Frontiers in plant science. vol 10. 2020-09-30. PMID:31263470. |
the results demonstrate that nutritional supplements influence cannabinoid content in cannabis in an organ- and spatial-dependent manner. |
2020-09-30 |
2023-08-13 |
Not clear |
| Nirit Bernstein, Jonathan Gorelick, Roei Zerahia, Sraya Koc. Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis ( Frontiers in plant science. vol 10. 2020-09-30. PMID:31263470. |
most importantly, the results confirm the potential of environmental factors to regulate concentrations of individual cannabinoids in medical cannabis. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pramod Theetha Kariyanna, Apoorva Jayarangaiah, Oleg Yurevich, Jonathan Francois, Denis Yusupov, Angelina Zhyvotovska, Louis Salciccioli, Sudhanva Hegde, Samy I McFarlan. Atrioventricular Nodal Reentrant Tachycardia Triggered by Marijuana Use: A Case Report and Review of the Literature. American journal of medical case reports. vol 7. issue 9. 2020-09-30. PMID:31396556. |
delta-9-tetrahydrocannabinol (thc) is the psychotropic component of marijuana, acting via cb1 and cb2 g-protein coupled cannabinoid receptors. |
2020-09-30 |
2023-08-13 |
Not clear |
| Igor Grant, B Rael Cah. Cannabis and endocannabinoid modulators: Therapeutic promises and challenges. Clinical neuroscience research. vol 5. issue 2-4. 2020-09-29. PMID:18806886. |
cannabis and endocannabinoid modulators: therapeutic promises and challenges. |
2020-09-29 |
2023-08-12 |
Not clear |
| Igor Grant, B Rael Cah. Cannabis and endocannabinoid modulators: Therapeutic promises and challenges. Clinical neuroscience research. vol 5. issue 2-4. 2020-09-29. PMID:18806886. |
the discovery that botanical cannabinoids such as delta-9 tetrahydrocannabinol exert some of their effect through binding specific cannabinoid receptor sites has led to the discovery of an endocannabinoid signaling system, which in turn has spurred research into the mechanisms of action and addiction potential of cannabis on the one hand, while opening the possibility of developing novel therapeutic agents on the other. |
2020-09-29 |
2023-08-12 |
Not clear |
| Igor Grant, B Rael Cah. Cannabis and endocannabinoid modulators: Therapeutic promises and challenges. Clinical neuroscience research. vol 5. issue 2-4. 2020-09-29. PMID:18806886. |
the therapeutic action of botanical cannabis or of synthetic molecules that are agonists, antagonists, or which may otherwise modify endocannabinoid metabolism and activity indicates they may have promise as neuroprotectants, and may be of value in the treatment of certain types of pain, epilepsy, spasticity, eating disorders, inflammation, and possibly blood pressure control. |
2020-09-29 |
2023-08-12 |
Not clear |
| Julia Hermes-Laufer, Lola Del Puppo, Ihsan Inan, François-Xavier Troillet, Omar Khera. Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use. Case reports in gastrointestinal medicine. vol 2016. 2020-09-29. PMID:27980870. |
cannabinoid hyperemesis syndrome: a case report of cyclic severe hyperemesis and abdominal pain with long-term cannabis use. |
2020-09-29 |
2023-08-13 |
Not clear |
| Marco Colizzi, Sagnik Bhattacharyy. Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition. Current addiction reports. vol 4. issue 2. 2020-09-29. PMID:28580227. |
this article selectively reviews studies examining the distinctive effects of cannabinoids on human cognition, particularly those of delta-9-tetrahydrocannabinol (Δ9-thc) and cannabidiol (cbd). |
2020-09-29 |
2023-08-13 |
human |